What Pfizer can learn in Tennessee when it comes to vaccine rollout
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles. (Jim Weber/Daily Memphian)
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles.
Topics
Clint Hermes Stacey Schultz-Cherry vaccine Pfizer
Jane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers healthcare and higher education for The Daily Memphian.